The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase III randomized trial of chemotherapy with or without bevacizumab (B) in patients (pts) with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): Survival analysis of E1305, an ECOG-ACRIN Cancer Research Group trial.
 
Athanassios Argiris
Consulting or Advisory Role - Bristol-Myers Squibb; Debiopharm Group; Merck Serono; Roche
Speakers' Bureau - Merck Serono
Research Funding - Genentech/Roche
 
Shuli Li
No Relationships to Disclose
 
Panayiotis Savvides
No Relationships to Disclose
 
James Ohr
No Relationships to Disclose
 
Jill Gilbert
Leadership - American Board of Internal Medicine (ABIM)
Honoraria - Sanofi
Travel, Accommodations, Expenses - AstraZeneca
 
Marshall A. Levine
No Relationships to Disclose
 
Missak Haigentz
Stock and Other Ownership Interests - Roche
 
Nabil F. Saba
No Relationships to Disclose
 
Arnab Chakravarti
No Relationships to Disclose
 
Chukwuemeka Ikpeazu
No Relationships to Disclose
 
Charles Schneider
No Relationships to Disclose
 
Harlan Pinto
No Relationships to Disclose
 
Arlene A. Forastiere
Employment - NantHealth
Stock and Other Ownership Interests - NantHealth
 
Barbara Burtness
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Debiopharm Group; MedImmune; Merck; VentiRx
Research Funding - Merck